NHC National Healthcare Corp.

NHC Reports Third Quarter 2024 Earnings

(NYSE American: ), the nation's oldest publicly traded senior health care company, announced today net operating revenues and grant income for the quarter ended September 30, 2024 totaled $340,198,000 compared to $288,485,000 for the quarter ended September 30, 2023, an increase of 17.9%. The increase in net operating revenues for the third quarter of 2024 compared to the same period last year was primarily related to the August 1, 2024 acquisition of White Oak Manor (“White Oak”). The White Oak operations consist of 21 healthcare operations, which includes 15 skilled nursing facilities, two assisted living facilities, and four independent living facilities.

For the quarter ended September 30, 2024, the reported GAAP net income attributable to NHC was $42,789,000 compared to $10,388,000 for the same period in 2023. Excluding the unrealized gains or losses in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income for the quarter ended September 30, 2024 was $19,910,000 compared to $13,250,000 for the same period in 2023, an increase of 50.3% (*). The GAAP diluted earnings per share were $2.73 for the quarter ended September 30, 2024 compared to $0.68 for the quarter ended September 30, 2023. Adjusted diluted earnings per share were $1.27 and $0.86 for the quarters ended September 30, 2024 and 2023, respectively (*).

(*) - See the tables below that provide a reconciliation of GAAP to non-GAAP items.

About NHC

NHC affiliates operate for themselves and third parties 80 skilled nursing facilities with 10,349 beds. NHC affiliates also operate 26 assisted living communities with 1,413 units, nine independent living communities with 777 units, three behavioral health hospitals, 34 homecare agencies, and 32 hospice agencies. NHC’s other services include Alzheimer’s and memory care units, pharmacy services, a rehabilitation services company, and providing management and accounting services to third party post-acute operators. Other information about the company can be found on our web site at .

Non-GAAP Financial Presentation

The Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company’s operations and measure the Company’s performance more consistently across periods. Therefore, the Company believes this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.

Forward-Looking Statements

Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance. The risks and uncertainties are detailed from time to time in reports filed by NHC with the S.E.C., including Forms 8-K, 10-Q, and 10-K. All forward-looking statements represent NHC’s best judgment as of the date of this release.

Consolidated Statements of Operations
(in thousands, except share and per share amounts)

Three Months Ended

 

Nine Months Ended

September 30

 

September 30

 

2024

 

 

 

2023

 

 

 

2024

 

 

 

2023

 

(unaudited)

 

(unaudited)

Revenues and grant income:
Net patient revenues

$

328,674

 

$

277,005

 

$

894,415

 

$

804,617

 

Other revenues

 

11,524

 

 

11,480

 

 

34,172

 

 

36,013

 

Government stimulus income

 

-

 

 

-

 

 

9,445

 

 

-

 

Net operating revenues and grant income

 

340,198

 

 

288,485

 

 

938,032

 

 

840,630

 

 
Costs and expenses:
Salaries, wages and benefits

 

213,395

 

 

182,664

 

 

576,609

 

 

525,782

 

Other operating

 

82,509

 

 

72,490

 

 

238,092

 

 

217,213

 

Facility rent

 

10,886

 

 

10,094

 

 

31,804

 

 

30,087

 

Depreciation and amortization

 

10,619

 

 

10,135

 

 

30,543

 

 

30,266

 

Interest

 

1,742

 

 

77

 

 

1,788

 

 

268

 

Total costs and expenses

 

319,151

 

 

275,460

 

 

878,836

 

 

803,616

 

 
Income from operations

 

21,047

 

 

13,025

 

 

59,196

 

 

37,014

 

 
Non-operating income

 

4,224

 

 

4,097

 

 

14,865

 

 

12,116

 

Unrealized gains/(losses) on marketable equity securities

 

32,767

 

 

(3,093

)

 

56,290

 

 

2,943

 

 
Income before income taxes

 

58,038

 

 

14,029

 

 

130,351

 

 

52,073

 

Income tax provision

 

(15,338

)

 

(3,908

)

 

(34,294

)

 

(14,750

)

Net income

 

42,700

 

 

10,121

 

 

96,057

 

 

37,323

 

 
Net (income)/loss attributable to noncontrolling interest

 

89

 

 

267

 

 

(211

)

 

1,069

 

 
Net income attributable to National HealthCare Corporation

$

42,789

 

$

10,388

 

$

95,846

 

$

38,392

 

 
Net income per common share
Basic

$

2.78

 

$

0.68

 

$

6.23

 

$

2.51

 

Diluted

$

2.73

 

$

0.68

 

$

6.15

 

$

2.50

 

 
Weighted average common shares outstanding
Basic

 

15,411,680

 

 

15,299,913

 

 

15,384,758

 

 

15,311,453

 

Diluted

 

15,667,321

 

 

15,324,511

 

 

15,576,294

 

 

15,334,269

 

 
Dividends declared per common share

$

0.61

 

$

0.59

 

$

1.81

 

$

1.75

 

 
 
Balance Sheet Data

September 30

 

December 31

(in thousands)

 

2024

 

 

 

2023

 

(unaudited)

 

 

 
Cash, cash equivalents and marketable securities

$

249,561

 

$

223,620

 

Restricted cash, cash equivalents and marketable securities

 

177,179

 

 

167,971

 

Current assets

 

445,726

 

 

406,235

 

Property and equipment, net

 

686,425

 

 

493,329

 

Total assets

 

1,562,707

 

 

1,310,796

 

Current liabilities, excluding long-term debt due within one year

 

240,446

 

 

214,476

 

Current and long-term debt

 

147,000

 

 

-

 

NHC stockholders' equity

 

983,468

 

 

908,752

 

Selected Operating Statistics

Three Months Ended

 

Nine Months Ended

September 30

 

September 30

 

2024

 

 

 

2023

 

 

 

2024

 

 

 

2023

 

(unaudited)

 

(unaudited)

Skilled Nursing Per Diems:
Medicare

$

578.12

 

$

551.82

 

$

579.24

 

$

552.21

 

Managed Care

 

459.94

 

 

489.18

 

 

459.64

 

 

460.20

 

Medicaid

 

290.00

 

 

256.46

 

 

274.44

 

 

248.99

 

Private Pay and Other

 

323.36

 

 

283.49

 

 

315.09

 

 

279.12

 

 
Average Skilled Nursing Per Diem

$

350.85

 

$

325.34

 

(1)

$

344.76

 

(1)

$

320.09

 

(1)

 
Skilled Nursing Patient Days:
Medicare

 

79,957

 

 

75,215

 

 

235,715

 

 

239,228

 

Managed Care

 

70,635

 

 

61,979

 

 

199,023

 

 

179,992

 

Medicaid

 

344,940

 

 

290,887

 

 

906,265

 

 

852,074

 

Private Pay and Other

 

177,846

 

 

170,857

 

 

485,523

 

 

492,279

 

 
Total Skilled Nursing Patient Days

 

673,378

 

 

598,938

 

(1)

 

1,826,526

 

(1)

 

1,763,573

 

(1)

 
(1) NHC exited three skilled nursing facilities in Missouri on March 1, 2024. For the first quarter of 2024, the exited Missouri skilled nursing facilities had an average skilled nursing per diem of $259.56 and 20,267 patient days. For the three months ended September 30, 2023, the exited Missouri skilled nursing facilities had an average skilled nursing per diem of $244.20 and 32,141 patient days. For the nine months ended September 30, 2023, the exited Missouri skilled nursing facilities had an average skilled nursing per diem of $248.51 and 95,030 patient days.
 
The tables below provide reconciliations of GAAP to non-GAAP items (in thousands, except per share amounts):

Three Months Ended

 

Nine Months Ended

September 30

 

September 30

 

2024

 

 

 

2023

 

 

 

2024

 

 

 

2023

 

(unaudited)

 

(unaudited)

 
Net income attributable to National Healthcare Corporation

$

42,789

 

$

10,388

 

$

95,846

 

$

38,392

 

Non-GAAP adjustments
Unrealized (gains)/losses on marketable equity securities

 

(32,767

)

 

3,093

 

 

(56,290

)

 

(2,943

)

Operating results for newly opened operations not at full capacity (2)

 

120

 

 

66

 

 

140

 

 

1,616

 

Stock-based compensation expense

 

1,093

 

 

708

 

 

3,062

 

 

2,119

 

Gain on sale of unconsolidated company

 

-

 

 

-

 

 

(1,024

)

 

-

 

Acquisition-related expenses (3)

 

637

 

 

-

 

 

2,831

 

 

-

 

Employee retention credit

 

-

 

 

-

 

 

(9,445

)

 

-

 

Income tax provision on non-GAAP adjustments

 

8,038

 

 

(1,005

)

 

15,789

 

 

(206

)

Non-GAAP Net income

$

19,910

 

$

13,250

 

$

50,909

 

$

38,978

 

 
GAAP diluted earnings per share

$

2.73

 

$

0.68

 

$

6.15

 

$

2.51

 

Non-GAAP adjustments
Unrealized (gains)/losses on marketable equity securities

 

(1.55

)

 

0.15

 

 

(2.67

)

 

(0.14

)

Operating results for newly opened operations not at full capacity (2)

 

0.01

 

 

-

 

 

0.01

 

 

0.07

 

Stock-based compensation expense

 

0.05

 

 

0.03

 

 

0.15

 

 

0.10

 

Gain on sale of unconsolidated company

 

-

 

 

-

 

 

(0.05

)

 

-

 

Acquisition-related expenses (3)

 

0.03

 

 

-

 

 

0.13

 

 

-

 

Employee retention credit

 

-

 

 

-

 

 

(0.45

)

 

-

 

Non-GAAP diluted earnings per share

$

1.27

 

$

0.86

 

$

3.27

 

$

2.54

 

 
(2) The operating results for newly opened facilities or agencies not at full capacity include healthcare operations that are still considered in the start-up phase, which are two hospice agencies for the three and nine months ended September 30, 3024. For the three and nine months ended September 30, 2023, included are two behavioral health hospitals, two homecare agencies, and two hospice agencies.
(3) Represents expenses incurred to acquire the White Oak operations that are not capitalizable.

 

EN
08/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on National Healthcare Corp.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

OSK OSHKOSH CORP
DXCM DEXCOM INC.
XRAY DENTSPLY SIRONA INC.
WING WINGSTOP INC.
VRTS VIRTUS INVESTMENT PARTNERS INC.
UHS UNIVERSAL HEALTH SERVICES INC. CLASS B
STKS ONE GROUP HOSPITALITY
SNPS SYNOPSYS INC.
SMG SCOTTS MIRACLE-GRO COMPANY CLASS A
SFST SOUTHERN FIRST BANCSHARES
RGNX REGENXBIO INC.
RCKY ROCKY BRANDS
PRGO PERRIGO CO. PLC
MPWR MONOLITHIC POWER SYSTEMS INC.
JRVR JAMES RIVER GROUP HOLDINGS LTD
IRM IRON MOUNTAIN INC.
GPC GENUINE PARTS COMPANY
GD GENERAL DYNAMICS CORPORATION
DLTR DOLLAR TREE INC.
DG DOLLAR GENERAL CORPORATION
CROX CROCS INC.
CAL CALERES INC.
BKE BUCKLE INC.
ASC ARDMORE SHIPPING
AMOT ALLIED MOTION TECHNOLOGIES
ACAD ACADIA PHARMACEUTICALS INC.
SBL SAFE BULKERS INC.
LPG DORIAN LPG
MEG. MEG ENERGY CORP.
MDU MDU RESOURCES GROUP INC
NAT NORDIC AMERICAN TANKERS LIMITED
EVTC EVERTEC INC.
FSLR FIRST SOLAR INC.
IONS IONIS PHARMACEUTICALS INC.
NMIH NMI HOLDINGS INC. CLASS A
AGYS AGILYSYS INC.
SJM J.M. SMUCKER COMPANY
FIZZ NATIONAL BEVERAGE CORP.
NHC NATIONAL HEALTHCARE CORP.
INSW INTERNATIONAL SEAWAYS INC.
FLGT FULGENT GENETICS
DK DELEK US HOLDINGS INC
CELH CELSIUS HOLDINGS INC.
AMD ADVANCED MICRO DEVICES INC.
TTEC TTEC HOLDINGS INC.
AVGO BROADCOM INC.
ST SENSATA TECHNOLOGIES HOLDING PLC
ELAN ELANCO ANIMAL HEALTH INC.
MEC MAYVILLE ENGINEERING
DELL DELL TECHNOLOGIES INC CLASS C
CSTM CONSTELLIUM SE CLASS A
OI O-I GLASS INC
BWMN BOWMAN CONSULTING GROUP LTD
DINO HOLLYFRONTIER CORP
EVEX EVE HOLDING INC
SPXC SPX TECHNOLOGIES INC
WEST WESTROCK COFFEE COMPANY LLC
ADCT ADC THERAPEUTICS SA
SVV SAVERS VALUE VILLAGE INC
GUTS FRACTYL HEALTH INC
AGEN AGENUS INC.
ARDT ARDENT HEALTH PARTNERS INC
PCT PROVIDENT CAP TR II SKIS 8.75%29
MKTW MARKETWISE INC
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Expecting a Test of All-Time Highs The market remains relentlessly strong, shrugging off the latest "bearish" headline regarding Moody's U.S. debt downgrade on Friday. This is exactly what we would expect to happen in a bull market, particularly during this "lockout rally," and helps confirm our bullish outlook. To recap, we have been short-term bullish since our 4/22/25 Compass -- when the SPX was testing 5100-5120 support -- but we upgraded our intermediate-term outlook to bullish as well, as...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: May 10, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

DHIL DIAMOND HILL INVESTMENT GROUP
RGR STURM RUGER & COMPANY INC.
PEB PEBBLEBROOK HOTEL TRUST
PCAR PACCAR INC
NG. NOVAGOLD RESOURCES INC.
NBTB NBT BANCORP INC.
MTX MINERALS TECHNOLOGIES INC.
MTDR MATADOR RESOURCES COMPANY
MMLP MARTIN MIDSTREAM PARTNERS L.P.
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC.
HUN HUNTSMAN CORPORATION
HL HECLA MINING COMPANY
CHDN CHURCHILL DOWNS INCORPORATED
CFFN CAPITOL FEDERAL FINANCIAL INC.
CBRL CRACKER BARREL OLD COUNTRY STORE INC.
BIIB BIOGEN INC.
APLE APPLE HOSPITALITY REIT INC
OFIX ORTHOFIX INTERNATIONAL N.V.
CAT CATERPILLAR INC.
ARCB ARCBEST CORPORATION
HTLD HEARTLAND EXPRESS INC.
USAC USA COMPRESSION PARTNERS LP
NHC NATIONAL HEALTHCARE CORP.
JELD JELD-WEN HOLDING INC.
FCNCA FIRST CITIZENS BANCSHARES INC. CLASS A
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
OCSL OAKTREE SPECIALTY LENDING CORPORATION
SNBR SLEEP NUMBER CORPORATION
RCII RENT-A-CENTER INC
A2H9KJ NEO PERFORMANCE MATERIAL
KKR KKR & CO. INC.
REZI RESIDEO TECHNOLOGIES
TROX INC.
UTGN TRONOX HOLDINGS PLC
CCO UTG
AVTR CLEAR CHANNEL OUTDOOR HOLDINGS INC
GCI AVANTOR
DCTH INC.
ONEW GANNETT CO. INC.
DLHC DELCATH SYSTEMS
UTZ ONEWATER MARINE
OGN DALEIGH HOLDINGS CORP
NVCT UTZ BRANDS INC (A)
PRAA ORGANON & CO
VSTS_w NUVECTIS PHARMA INC
BNL PORTFOLIO RECOVERY ASSOCIATES
DMA INC.
SUNS VESTIS CORPORATION
GF BROADSTONE NET LEASE INC
FG DESTRA MULTI ALTERNATIVE FUND
EU SUNRISE REALTY TRUST
ECF THE NEW GERMANY FUND
HCWB INC.
F AND G ANNUITIES AND LIFE
INC.
WISDOMTREE EURO DEBT FUND
ELLSWORTH FUND LTD
HCW BIOLOGICS INC

ResearchPool Subscriptions

Get the most out of your insights

Get in touch